Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 16 May, 2014 and appeared in  DietCardiovascularObesityType 2 DiabetesIssue 729

The Potential of Low-Carbohydrate Diets to Reduce CVD Risk

Consuming low-carbohydrate diets can reduce inflammation in patients with type 2 diabetes which may decrease the risk of patients developing cardiovascular disease.... 

Advertisement

According to a Swedish study, eating a low-carbohydrate diet can reduce inflammation in patients with type 2 diabetes. People with type 2 diabetes have a higher level of inflammation than those without diabetes, and this may play a part in the increased risk of cardiovascular disease associated with diabetes. The Linkoping University study included 61 participants with type 2 diabetes. The participants were randomly divided up and given either a low-carbohydrate or low-fat diet. The study method was a retrospective follow-up. The low-carbohydrate diet and the low-fat diet were compared over the course of 2 years. Additionally, the researchers studied how the diets impacted inflammation by checking the inflammation levels in the blood of each patient.

The results showed that both the low-carbohydrate and low-fat diets helped participants lose weight, roughly around nine pounds, but when it came to which diet produced reduced inflammatory markers in the blood, the low-carbohydrate diet succeeded. Additionally, glucose-levels dropped more in the low-carbohydrate diet groups. The researchers recommended with respect to the cardiovascular risk involved, aiming carbohydrate energy intake to 20% as a treatment alternative for at-risk patients.

Practice Pearls:
  • Low-carbohydrate diets help aid in weight loss as well as reduce inflammatory markers in the blood, and drop glucose-levels
  • Reducing inflammation in patients with type 2 diabetes may have potential to decrease the risk of patients developing cardiovascular diseases in the future
  • With respect to the cardiovascular risk involved, aim carbohydrate energy intake to 20%, which can be established as a treatment alternative

Diabetologia. 2012 Aug;55(8):2118-27. doi: 10.1007/s00125-012-2567-4. Epub 2012 May 6

  

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  DietCardiovascularObesityType 2 DiabetesIssue 729

Past five issues: Issue 743 | Diabetes Clinical Mastery Series Issue 202 | SGLT-2 Inhibitors Special Edition August 2014 | GLP-1 Special Editions August 2014 | Issue 742 |

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
Statin Adherence Linked to New Onset Diabetes Risk
Posted July 25, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
HbA1c Increases with Age
Posted August 01, 2014
Connection between Type 1 Diabetes and Ulcerative Colitis?
Posted August 01, 2014
Regression from Prediabetes to Normal Glucose Reduces CVD Risk
Posted July 25, 2014
New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
Posted August 08, 2014
Comparing Weekly Dulaglutide to Daily Liraglutide
Posted August 01, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you recommend SGLT-2 drugs for type 1 diabetes?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control